Arya Bolurfrushan, the founder and chief executive of artificial intelligence startup AppliedAI, has secretly admitted his role in one of the most extensive insider trading conspiracies to surface in recent years, implicating dozens of people across major law firms and the financial markets. Court filings made public on Monday reveal that Bolurfrushan, a former Goldman Sachs investment banker based in Abu Dhabi, entered a guilty plea in June 2025 after negotiating with federal prosecutors in Boston who have been systematically dismantling what investigators describe as a long-running criminal enterprise where attorneys systematically leaked confidential information about pending mergers to co-conspirators in exchange for shares of trading profits.
The case represents a striking breach of professional ethics and fiduciary duty by attorneys who held access to some of the most sensitive financial information available through their work at prestigious law firms including Sidley Austin, Latham & Watkins, and Goodwin Procter. The guilty plea by Bolurfrushan came as prosecutors were preparing to pursue charges against roughly three dozen individuals implicated in the scheme, underscoring the scale and sophistication of the operation. In particular, prosecutors identified Nicolo Nourafchan, who held associate positions at multiple elite firms, as a central figure who systematically harvested confidential deal information and transmitted it to financial traders who capitalized on advance knowledge of corporate transactions.
Under his plea agreement, Bolurfrushan admitted to conspiring to commit securities fraud and accepted a sentencing recommendation of two years imprisonment alongside forfeiture of $954,496 in illicit trading gains. His lawyer, Jordan Estes of Gibson, Dunn & Crutcher, refrained from offering any public statement regarding the arrangement. The guilty plea represents a calculated decision by Bolurfrushan to cooperate with authorities and likely secure a reduced sentence compared to what he might face if convicted at trial. Nine additional co-conspirators similarly entered guilty pleas in confidential proceedings before the broader indictments were unsealed, suggesting that federal prosecutors have been methodically flipping participants to build an airtight case against those maintaining not guilty pleas.
According to court documents and regulatory filings, Nourafchan and his partner, personal injury attorney Robert Yadgarov, served as the primary sources of insider information, feeding Bolurfrushan with advance notice of major transactions in exchange for a percentage of his trading profits. Bolurfrushan had initially made contact with this group through a family member of Nourafchan's and was successfully recruited into the conspiracy while working in Dubai during 2023. The mechanics of the scheme were straightforward but effective: Nourafchan, leveraging his position as an associate at Goodwin Procter, would gain access to restricted information about corporate transactions and relay it directly to Bolurfrushan, who would then execute trades using this non-public knowledge to generate substantial gains.
A particularly instructive example of the conspiracy involved the acquisition of biopharmaceutical company Orchard Therapeutics by Japan's Kyowa Kirin Co Ltd. In September 2023, Nourafchan accessed confidential deal documents concerning this transaction despite having no official role in the matter. He promptly informed Bolurfrushan of the impending takeover, enabling him to purchase Orchard securities before the announcement became public. The trading proved remarkably profitable: Bolurfrushan generated approximately $950,000 in gains from this single transaction alone, of which roughly $60,000 was passed along to Nourafchan and Yadgarov as their agreed-upon compensation. The efficiency of this profit-sharing arrangement demonstrates how the conspirators had refined their operation into a well-oiled criminal enterprise.
The scheme continued unabated into mid-2024, when Bolurfrushan obtained and acted upon another tip regarding Sixth Street's proposed $5.1 billion acquisition of insurance firm Enstar. This second major transaction reinforced federal investigators' assessment that the conspiracy represented not isolated incidents but rather a systematic pattern of criminal conduct spanning multiple years and numerous transactions. The breadth of the operation—touching multiple law firms, various financial markets, and many individual traders—suggests that institutional safeguards at these prominent legal practices failed to detect or prevent the unauthorised disclosure of confidential client information.
The parallel civil enforcement action pursued by the US Securities and Exchange Commission against Bolurfrushan was settled on the same Monday that court records were unsealed, providing additional regulatory consequences beyond criminal penalties. The SEC's findings corroborated the prosecution's characterisation of Bolurfrushan's conduct and placed it within the broader context of securities law violations that harm market integrity and investor confidence. For Bolurfrushan specifically, this combination of criminal guilty plea, agreed prison sentence, financial forfeiture, and civil settlement demonstrates the multiple layers of legal jeopardy faced by participants in insider trading schemes once discovered.
Notably, Nourafchan and Yadgarov have maintained not guilty pleas to charges of securities fraud and related offences, positioning themselves for trial rather than accepting responsibility. Their decision to contest the charges contrasts sharply with Bolurfrushan's admission and cooperation, potentially reflecting differing assessments of the strength of the prosecution's evidence or divergent legal strategies. The approaching trial will likely expose further details about how these attorneys operated, which clients' information they exploited, and the sophistication of their methods for concealing the scheme from their employers and regulatory authorities.
For the Malaysian and Southeast Asian investment community, this case offers cautionary lessons about the vulnerabilities inherent in relying upon information intermediaries and the reputational risks associated with major international law firms. While insider trading remains a serious offence in Malaysian securities markets under the Capital Markets and Services Act, the cross-border nature of international M&A activity means that Malaysian investors and firms engaged in overseas transactions must understand that counterparty conduct in foreign jurisdictions carries legal and ethical implications. The involvement of law firms with global practices underscores that misconduct can occur at even the most prestigious institutions, warranting continued investor vigilance and regulatory coordination across jurisdictions.
The unmasking of this extensive conspiracy has already prompted increased scrutiny of information barriers and compliance procedures at law firms handling sensitive transactional work. Investment banks and trading firms are reassessing their due diligence protocols regarding the sources of market intelligence and their obligations to report suspicions of unlawful conduct. For market regulators globally, including Malaysia's Securities Commission, the case reinforces the need for enhanced surveillance mechanisms and closer inter-agency cooperation to identify patterns suggestive of systematic insider trading before such schemes become entrenched across multiple transactions and institutions.
